Indegene maximized MLR review compliance for one of the world's largest global biotech organizations, transforming scientific innovation into medicines for patients with serious illnesses. Challenges included balancing marketers' push for faster asset delivery against regulators' stringent demands for fair-balanced, accurate information, plus an explosion in promotional/non-promotional asset volumes overwhelming the review process. Indegene's software automated compliance checks, streamlined workflows between stakeholders, and scaled efficiently to handle surging volumes while upholding rigorous standards for patient safety and regulatory protection.

Join for free to read